1. Background
2. Objectives
3. Methods
3.1. Materials
3.2. Animals
3.3. Preparation of Nanoparticles
3.4. Size and Morphology of Nanoparticles
3.4.1. Isolation of Mitochondria
3.4.2. Protein Measurements
3.5. Dose Assessment of MWCNTs
3.6. Determination of Complex II Activity Using MTT Assay
3.7. Mitochondrial ROS Level Assay
3.8. Measurement of Malondialdehyde Levels
3.9. Measurement of GSH Level
3.10. Determination of CAT Activity
3.11. MMP Measurement
3.12. Statistical Analyses
4. Results
4.1. Dose Optimization of MWCNTs
4.2. Effect of CA on Viability Rate of Mitochondria Exposed to MWCNTs
4.3. Effect of CA on Oxidative Stress in MWCNT-Treated Mitochondria
4.4. Effect of CA on MDA Levels in Mitochondria Exposed to MWCNTs
4.5. Effect of CA on GSH in Mitochondria Exposed to MWCNTs
4.6. Effect of CA on CAT Activity in Mitochondria Exposed to MWCNTs
4.7. Effect of CA on MMP in Mitochondria Exposed to MWCNTs
Effect of caffeic acid on the mitochondrial MDA, GSH, and catalase activity in rat Kidney mitochondria exposed to MWCNTs. Results of treatment groups were compared with the control group ** P < 0.01, *** P < 0.001, **** P < 0.0001) and MWCNTs 160 (#P < 0.05, ## P < 0.01, ### P < 0.001). Values are expressed as mean ± SD.



